Literature DB >> 22763336

Gendered symptom presentation in acute coronary syndrome: a cross sectional analysis.

Sharon O'Donnell1, Gabrielle McKee, Frances O'Brien, Mary Mooney, Debra K Moser.   

Abstract

BACKGROUND: The international literature suggests that the symptom presentation of acute coronary syndrome may be different for men and women, yet no definitive conclusion about the existence of gendered presentation in ACS has been provided.
OBJECTIVE: This study examines whether gendered symptom presentation exists in a well-defined sample of men and women with ACS. DESIGN AND
SETTING: A cross-sectional analysis of baseline data pertaining to symptom experience and medical profiles were recorded for all ACS patients who participated in a multi-centered randomized control trial, in 5 hospitals, in Dublin, Ireland. PARTICIPANTS: : Patients were deemed eligible if they were admitted through the Emergency Department (ED) with a diagnosis of ACS, if they were at least 21 years of age and able to read and converse in English. Patients were excluded if they had serious co-morbidities, cognitive, hearing or vision impairment.
METHODS: Patients were interviewed 2-4 days following their ACS event and data was gathered using the ACS response to symptom index.
RESULTS: The study included 1947 patients of whom 28% (n=545) were women. Chest pain was the most commonly experienced symptom in men and women, reported by 71% of patients. Using logistic regression and adjusting for clinical and demographic variables, women had greater odds of experiencing shortness of breath (50% vs 43%; odds ratio [OR]=1.32; 95% CI=1.08-1.62; p=.006) palpitations (5.5% vs 2.8%; OR=2.17; CI=1.31-3.62; p=.003) left arm pain (34% vs 30.5%; OR=1.27; CI=1.02-1.58; p=.03) back pain (7.5% vs 4.8%; OR=1.56; CI=1.03-2.37; p=.034) neck or jaw pain (21.5% vs 13.8%; OR=1.84; CI=1.41-2.40; p=.001) nausea (28% vs 24%; OR=1.30; CI=1.03-1.65; p=.024) a sense of dread (13.4% vs 10.5%; OR=1.47; CI=1.08-2.00; p=.014) and fatigue (29% vs 21.5%; OR=1.64; CI=1.29-2.07; p=.001) than their male counterparts.
CONCLUSIONS: Although chest pain is the most commonly experienced symptom by men and women, other ACS symptomology may differ significantly between genders.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22763336     DOI: 10.1016/j.ijnurstu.2012.06.002

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  5 in total

1.  The Quality of Symptoms in Women and Men Presenting to the Emergency Department With Suspected Acute Coronary Syndrome.

Authors:  Sahereh Mirzaei; Alana Steffen; Karen Vuckovic; Catherine Ryan; Ulf Bronas; Jessica Zegre-Hemsey; Holli A DeVon
Journal:  J Emerg Nurs       Date:  2019-02-07       Impact factor: 1.836

2.  A Qualitative Study of Symptom Experiences of Women With Acute Coronary Syndrome.

Authors:  Leslie L Davis
Journal:  J Cardiovasc Nurs       Date:  2017 Sep/Oct       Impact factor: 2.083

3.  Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.

Authors:  Kshipra Hemal; Neha J Pagidipati; Adrian Coles; Rowena J Dolor; Daniel B Mark; Patricia A Pellikka; Udo Hoffmann; Sheldon E Litwin; Melissa A Daubert; Svati H Shah; Kevin Ariani; Renée P Bullock-Palmer; Beth Martinez; Kerry L Lee; Pamela S Douglas
Journal:  JACC Cardiovasc Imaging       Date:  2016-04

Review 4.  Correlates of palpitations during menopause: A scoping review.

Authors:  Janet S Carpenter; Ying Sheng; Caitlin Pike; Charles D Elomba; Jennifer S Alwine; Chen X Chen; James E Tisdale
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

5.  Sex Differences in Symptom Presentation in Acute Coronary Syndromes: A Systematic Review and Meta-analysis.

Authors:  Roos E M van Oosterhout; Annemarijn R de Boer; Angela H E M Maas; Frans H Rutten; Michiel L Bots; Sanne A E Peters
Journal:  J Am Heart Assoc       Date:  2020-05-04       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.